Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)
China · Delayed Price · Currency is CNY 22.68
+0.66 (3.00%)
Sep 30, 2026, 3:04 PM CST
SHE:300702 Revenue
Zhejiang Tianyu Pharmaceutical had revenue of 1.20B CNY in the quarter ending June 30, 2026, with 17.97% growth. This brings the company's revenue in the last twelve months to 3.30B, up 4.93% year-over-year. In the year 2025, Zhejiang Tianyu Pharmaceutical had annual revenue of 3.06B with 16.36% growth.
Revenue (ttm)
3.30B
Revenue Growth
+4.93%
P/S Ratio
2.37
Revenue / Employee
703.39K
Employees
4,686
Market Cap
7.83B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.06B | 430.33M | 16.36% |
| Dec 31, 2024 | 2.63B | 103.54M | 4.10% |
| Dec 31, 2023 | 2.53B | -139.41M | -5.23% |
| Jan 1, 2023 | 2.67B | 121.67M | 4.78% |
| Jan 1, 2022 | 2.55B | -42.39M | -1.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.